Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2013, Article ID 432659, 10 pages
http://dx.doi.org/10.1155/2013/432659
Research Article

Pronerve Growth Factor Induces Angiogenesis via Activation of TrkA: Possible Role in Proliferative Diabetic Retinopathy

1Center for Pharmacy and Experimental Therapeutics, University of Georgia, 1120 15th Street HM-1200, Augusta, GA 30912, USA
2Culver Vision Discovery Institute, Georgia Reagents University, Augusta, GA 30912, USA
3Charlie Norwood VA Medical Center, Augusta, GA 30912, USA
4Department of Physiology, Georgia Reagents University, Augusta, Georgia 30912, USA
5Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA

Received 30 April 2013; Revised 4 July 2013; Accepted 12 July 2013

Academic Editor: Mohamed Al-Shabrawey

Copyright © 2013 Sally L. Elshaer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. M. Bressler, A. R. Edwards, R. W. Beck et al., “Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation,” Archives of Ophthalmology, vol. 127, no. 12, pp. 1566–1571, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. T. K. Ali and A. B. El-Remessy, “Diabetic retinopathy: current management and experimental therapeutic targets,” Pharmacotherapy, vol. 29, no. 2, pp. 182–192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Noma, H. Funatsu, M. Yamasaki et al., “Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion,” Eye, vol. 22, no. 1, pp. 42–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Kroll, E. B. Rodrigues, and S. Hoerle, “Pathogenesis and classification of proliferative diabetic vitreoretinopathy,” Ophthalmologica, vol. 221, no. 2, pp. 78–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Whitmire, M. M. H. Al-Gayyar, M. Abdelsaid, B. K. Yousufzai, and A. B. El-Remessy, “Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far,” Molecular Vision, vol. 17, pp. 300–308, 2011. View at Google Scholar · View at Scopus
  6. J. Tang and T. S. Kern, “Inflammation in diabetic retinopathy,” Progress in Retinal and Eye Research, vol. 30, no. 5, pp. 343–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. B. El-Remessy, M. Al-Shabrawey, Y. Khalifa, N.-T. Tsai, R. B. Caldwell, and G. I. Liou, “Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes,” American Journal of Pathology, vol. 168, no. 1, pp. 235–244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. Ola, M. I. Nawaz, A. A. El-Asrar, M. Abouammoh, and A. S. Alhomida, “Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats,” Cellular and Molecular Neurobiology, no. 33, pp. 359–367, 2013. View at Google Scholar
  9. K. S. Park, S. S. Kim, J. C. Kim et al., “Serum and tear levels of nerve growth factor in diabetic retinopathy patients,” American Journal of Ophthalmology, vol. 145, no. 3, pp. 432–437, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. K. Ali, M. M. H. Al-Gayyar, S. Matragoon et al., “Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury,” Diabetologia, vol. 54, no. 3, pp. 657–668, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. H. Al-Gayyar, S. Matragoon, B. A. Pillai, T. K. Ali, M. A. Abdelsaid, and A. B. El-Remessy, “Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor proNGF expression in a rat model of diabetes,” Diabetologia, vol. 54, no. 3, pp. 669–680, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Micera, A. Lambiase, B. Stampachiacchiere, S. Bonini, S. Bonini, and F. Levi-Schaffer, “Nerve growth factor and tissue repair remodeling: trkANGFR and p75NTR, two receptors one fate,” Cytokine and Growth Factor Reviews, vol. 18, no. 3-4, pp. 245–256, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Micera, A. Lambiase, I. Puxeddu et al., “Nerve growth factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing,” Experimental Eye Research, vol. 83, no. 4, pp. 747–757, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Graiani, C. Emanueli, E. Desortes et al., “Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of type 1 diabetic mice,” Diabetologia, vol. 47, no. 6, pp. 1047–1054, 2004. View at Google Scholar · View at Scopus
  15. M. Meloni, A. Caporali, G. Graiani et al., “Nerve growth factor promotes cardiac repair following myocardial infarction,” Circulation Research, vol. 106, no. 7, pp. 1275–1284, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. S. von Bartheld, “Neurotrophins in the developing and regenerating visual system,” Histology and Histopathology, vol. 13, no. 2, pp. 437–459, 1998. View at Google Scholar · View at Scopus
  17. M. Blais, P. Lévesque, S. Bellenfant, and F. Berthod, “Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model,” Tissue Engineering A, vol. 19, no. 15-16, pp. 1655–1664, 2013. View at Publisher · View at Google Scholar
  18. C. S. Jadhao, A. D. Bhatwadekar, Y. Jiang, M. E. Boulton, J. J. Steinle, and M. B. Grant, “Nerve growth factor promotes endothelial progenitor cell-mediated angiogenic responses,” Investigative Ophthalmology & Visual Science, vol. 53, pp. 2030–2037, 2012. View at Google Scholar
  19. R. Lee, P. Kermani, K. K. Teng, and B. L. Hempstead, “Regulation of cell survival by secreted proneurotrophins,” Science, vol. 294, no. 5548, pp. 1945–1948, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. Abdelsaid, B. A. Pillai, S. Matragoon, R. Prakash, M. Al-Shabrawey, and A. B. El-Remessy, “Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy,” The Journal of Pharmacology and Experimental Therapeutics, vol. 332, no. 1, pp. 125–134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. LeSauteur, L. Wei, B. F. Gibbs, and H. U. Saragovi, “Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses,” The Journal of Biological Chemistry, vol. 270, no. 12, pp. 6564–6569, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Abdelsaid and A. B. El-Remessy, “S-glutathionylation of LMW-PTP regulates VEGF-mediated FAK activation and endothelial cell migration,” Journal of Cell Science, vol. 125, pp. 4751–4760, 2012. View at Publisher · View at Google Scholar
  23. A. B. El-Remessy, M. Al-Shabrawey, D. H. Platt et al., “Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells,” FASEB Journal, vol. 21, no. 10, pp. 2528–2539, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Kozak, A. Ergul, A. B. El-Remessy et al., “Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke,” Stroke, vol. 40, no. 5, pp. 1870–1876, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Liu, D. Wang, Y. Liu et al., “Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model,” Investigative Ophthalmology & Visual Science, vol. 51, no. 7, pp. 3749–3757, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Kim, Q. Li, B. L. Hempstead, and J. A. Madri, “Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells,” The Journal of Biological Chemistry, vol. 279, no. 32, pp. 33538–33546, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. T. K. Ali, S. Matragoon, B. A. Pillai, G. I. Liou, and A. B. El-Remessy, “Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes,” Diabetes, vol. 57, no. 4, pp. 889–898, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Loukovaara, A. Robciuc, J. M. Holopainen et al., “Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy,” Acta Ophthalmologica, 2012. View at Publisher · View at Google Scholar
  29. N. Mohan, F. Monickaraj, M. Balasubramanyam, M. Rema, and V. Mohan, “Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy,” Journal of Diabetes and Its Complications, vol. 26, pp. 435–441, 2012. View at Publisher · View at Google Scholar
  30. Y. Suzuki, M. Nakazawa, K. Suzuki, H. Yamazaki, and Y. Miyagawa, “Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion,” Japanese Journal of Ophthalmology, vol. 55, no. 3, pp. 256–263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H. F. Elewa, A. B. El-Remessy, P. R. Somanath, and S. C. Fagan, “Diverse effects of statins on angiogenesis: new therapeutic avenues,” Pharmacotherapy, vol. 30, no. 2, pp. 169–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Boodhwani and F. W. Sellke, “Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress,” Antioxidants & Redox Signaling, vol. 11, no. 8, pp. 1945–1959, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Emanueli and P. Madeddu, “Therapeutic angiogenesis: translating experimental concepts to medically relevant goals,” Vascular Pharmacology, vol. 45, no. 5, pp. 334–339, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. M. B. Salis, G. Graiani, E. Desortes, R. B. Caldwell, P. Madeddu, and C. Emanueli, “Nerve growth factor supplementation reverses the impairment, induced by type 1 diabetes, of hindlimb post-ischaemic recovery in mice,” Diabetologia, vol. 47, no. 6, pp. 1055–1063, 2004. View at Google Scholar · View at Scopus
  35. S. T. Azar, S. C. Major, and B. Safieh-Garabedian, “Altered plasma levels of nerve growth factor and transforming growth factor-β2 in type-1 diabetes mellitus,” Brain, Behavior, and Immunity, vol. 13, no. 4, pp. 361–366, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Cantarella, L. Lempereur, M. Presta et al., “Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo,” FASEB Journal, vol. 16, no. 10, pp. 1307–1309, 2002. View at Google Scholar · View at Scopus
  37. J.-P. Dollé, A. Rezvan, F. D. Allen, P. Lazarovici, and P. I. Lelkes, “Nerve growth factor-induced migration of endothelial cells,” The Journal of Pharmacology and Experimental Therapeutics, vol. 315, no. 3, pp. 1220–1227, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Lazarovici, A. Gazit, I. Staniszewska, C. Marcinkiewicz, and P. I. Lelkes, “Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane,” Endothelium, vol. 13, no. 1, pp. 51–59, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Alhusban, A. Kozak, A. Ergul, and S. C. Fagan, “AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator,” The Journal of Pharmacology and Experimental Therapeutics, vol. 344, pp. 348–359, 2013. View at Publisher · View at Google Scholar
  40. L. Shen, W. Zeng, Y. X. Wu et al., “Neurotrophin-3 accelerates wound healing in diabetic mice by promoting a paracrine response in mesenchymal stem cells,” Cell Transplantation, vol. 22, no. 6, pp. 1011–1021, 2012. View at Publisher · View at Google Scholar
  41. Y. Demont, C. Corbet, A. Page et al., “Pro-nerve growth factor induces autocrine stimulation of breast cancer cell invasion through tropomyosin-related kinase A (TrkA) and sortilin protein,” The Journal of Biological Chemistry, vol. 287, no. 3, pp. 1923–1931, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. M. M. Berg, D. W. Sternberg, L. F. Parada, and M. V. Chao, “K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity,” The Journal of Biological Chemistry, vol. 267, no. 1, pp. 13–16, 1992. View at Google Scholar · View at Scopus
  43. S. O. Yoon, S. P. Soltoff, and M. V. Chao, “A dominant role of the juxtamembrane region of the TrkA nerve growth factor receptor during neuronal cell differentiation,” The Journal of Biological Chemistry, vol. 272, no. 37, pp. 23231–23238, 1997. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Lagadec, S. Meignan, E. Adriaenssens et al., “TrkA overexpression enhances growth and metastasis of breast cancer cells,” Oncogene, vol. 28, no. 18, pp. 1960–1970, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. V. Freund-Michel, C. Bertrand, and N. Frossard, “TrkA signalling pathways in human airway smooth muscle cell proliferation,” Cellular Signalling, vol. 18, no. 5, pp. 621–627, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. S. J. Baker and E. P. Reddy, “Modulation of life and death by the TNF receptor superfamily,” Oncogene, vol. 17, no. 25, pp. 3261–3270, 1998. View at Google Scholar · View at Scopus
  47. A. B. Cragnolini and W. J. Friedman, “The function of p75NTR in glia,” Trends in Neurosciences, vol. 31, no. 2, pp. 99–104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. C. F. Ibáez, “Jekyll-Hyde neurotrophins: the story of proNGF,” Trends in Neurosciences, vol. 25, no. 6, pp. 284–286, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. P. P. Roux and P. A. Barker, “Neurotrophin signaling through the p75 neurotrophin receptor,” Progress in Neurobiology, vol. 67, no. 3, pp. 203–233, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. M. M. H. Al-Gayyar, B. A. Mysona, S. Matragoon et al., “Diabetes and overexpression of proNGF cause retinal neurodegeneration via activation of RhoA pathway,” PLoS One, vol. 8, no. 1, Article ID e54692, 2013. View at Publisher · View at Google Scholar
  51. A. B. El-Remessy, M. M. H. Al-Gayyar, S. Matragoon, and H. U. Saragovi, “Overexpression of ProNGF induces apoptosis and acellular capillary formation via activation of p75NTR,” Investigative Ophthalmology & Visual Science, vol. 53, article 5570, 2012. View at Google Scholar
  52. R. S. Kenchappa, N. Zampieri, M. V. Chao et al., “Ligand-dependent cleavage of the P75 neurotrophin receptor is necessary for NRIF nuclear translocation and apoptosis in sympathetic neurons,” Neuron, vol. 50, no. 2, pp. 219–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Matragoon, M. M. H. Al-Gayyar, B. A. Mysona et al., “Electroporation-mediated gene delivery of cleavage-resistant pro-nerve growth factor causes retinal neuro- and vascular degeneration,” Molecular Vision, vol. 18, pp. 2993–3003, 2012. View at Google Scholar
  54. F. Lebrun-Julien, M. J. Bertrand, O. de Backer et al., “ProNGF induces TNFα-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 8, pp. 3817–3822, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. B. A. Mysona, M. A. Abdelsaid, S. Matragoon, B. A. Pillai, and A. B. El-Remessy, “Inflammatory role of ProNGF/p75NTR in muller cells of the diabetic retina,” Investigative Ophthalmology & Visual Science, vol. 53, article 2003, 2012. View at Google Scholar
  56. A. Caporali, E. Pani, A. J. G. Horrevoets et al., “Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles,” Circulation Research, vol. 103, no. 2, pp. e15–e26, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Grade, Y. C. Weng, M. Snapyan, J. Kriz, J. O. Malva, and A. Saghatelyan, “Brain-derived neurotrophic factor promotes vasculature-associated migration of neuronal precursors toward the ischemic striatum,” PLoS ONE, vol. 8, no. 1, Article ID e55039, 2013. View at Publisher · View at Google Scholar
  58. M. Snapyan, M. Lemasson, M. S. Brill et al., “Vasculature guides migrating neuronal precursors in the adult mammalian forebrain via brain-derived neurotrophic factor signaling,” The Journal of Neuroscience, vol. 29, no. 13, pp. 4172–4188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. L. W. Meuchel, M. A. Thompson, S. D. Cassivi, C. M. Pabelick, and Y. S. Prakash, “Neurotrophins induce nitric oxide generation in human pulmonary artery endothelial cells,” Cardiovascular Research, vol. 91, no. 4, pp. 668–676, 2011. View at Publisher · View at Google Scholar · View at Scopus